The cost of clear skin: balancing the social and safety costs of iPLEDGE with the efficacy of Accutane (isotretinoin)
- PMID: 17294569
Item in Clipboard
The cost of clear skin: balancing the social and safety costs of iPLEDGE with the efficacy of Accutane (isotretinoin)
Seton Hall Law Rev.
2007.
No abstract available
Similar articles
-
A pox on your practice. iPLEDGE program scars dermatologists.Tex Med. 2006 May;102(5):29-31. Tex Med. 2006. PMID: 17115578 No abstract available.
-
Accutane risk management program strengthened.FDA Consum. 2002 Jan-Feb;36(1):8. FDA Consum. 2002. PMID: 11881607 No abstract available.
-
Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.Arch Dermatol. 2005 May;141(5):563-9. doi: 10.1001/archderm.141.5.563. Arch Dermatol. 2005. PMID: 15897377
-
What is the best approach to reducing birth defects associated with isotretinoin?PLoS Med. 2006 Nov;3(11):e483. doi: 10.1371/journal.pmed.0030483. PLoS Med. 2006. PMID: 17121451 Free PMC article. Review.
-
Safety and side effects of the acne drug, oral isotretinoin.Expert Opin Drug Saf. 2004 Mar;3(2):119-29. doi: 10.1517/eods.3.2.119.27340. Expert Opin Drug Saf. 2004. PMID: 15006718 Review.
Cited by
-
Reiterative Mechanisms of Retinoic Acid Signaling during Vertebrate Heart Development.J Dev Biol. 2019 May 30;7(2):11. doi: 10.3390/jdb7020011. J Dev Biol. 2019. PMID: 31151214 Free PMC article. Review.
-
Differences in isotretinoin start, interruption, and early termination across race and sex in the iPLEDGE era.PLoS One. 2019 Mar 26;14(3):e0210445. doi: 10.1371/journal.pone.0210445. eCollection 2019. PLoS One. 2019. PMID: 30913210 Free PMC article.
-
Patterning of vertebrate cardiac progenitor fields by retinoic acid signaling.Genesis. 2021 Nov;59(11):e23458. doi: 10.1002/dvg.23458. Epub 2021 Oct 19. Genesis. 2021. PMID: 34665508 Free PMC article. Review.
-
Risk management policy and black-box warnings: a qualitative analysis of US FDA proceedings.Drug Saf. 2009;32(11):1057-66. doi: 10.2165/11316670-000000000-00000. Drug Saf. 2009. PMID: 19810777
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical